ATE445704T1 - Expressionsvektor für tierische zellen - Google Patents

Expressionsvektor für tierische zellen

Info

Publication number
ATE445704T1
ATE445704T1 AT01957013T AT01957013T ATE445704T1 AT E445704 T1 ATE445704 T1 AT E445704T1 AT 01957013 T AT01957013 T AT 01957013T AT 01957013 T AT01957013 T AT 01957013T AT E445704 T1 ATE445704 T1 AT E445704T1
Authority
AT
Austria
Prior art keywords
vector
expression vector
present
animal cells
expression
Prior art date
Application number
AT01957013T
Other languages
English (en)
Inventor
Jong-Mook Kim
Jung-Seob Kim
Sun-Mo Oh
Jae-Seung Yoon
Kwang-Hee Baek
Soo-Il Chung
Doo-Hong Park
Yeup Yoon
Original Assignee
Mogam Biotech Res Inst
Neurotech Pharmaceuticals Co L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mogam Biotech Res Inst, Neurotech Pharmaceuticals Co L filed Critical Mogam Biotech Res Inst
Application granted granted Critical
Publication of ATE445704T1 publication Critical patent/ATE445704T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4717—Plasma globulins, lactoglobulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT01957013T 2000-07-29 2001-07-27 Expressionsvektor für tierische zellen ATE445704T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2000-0043996A KR100408844B1 (ko) 2000-07-29 2000-07-29 동물세포 발현벡터
PCT/KR2001/001285 WO2002014525A2 (en) 2000-07-29 2001-07-27 Expression vector using for animal cell

Publications (1)

Publication Number Publication Date
ATE445704T1 true ATE445704T1 (de) 2009-10-15

Family

ID=19680759

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01957013T ATE445704T1 (de) 2000-07-29 2001-07-27 Expressionsvektor für tierische zellen

Country Status (10)

Country Link
US (1) US7422874B2 (de)
EP (1) EP1392835B1 (de)
JP (1) JP4138479B2 (de)
KR (1) KR100408844B1 (de)
CN (1) CN1262663C (de)
AT (1) ATE445704T1 (de)
AU (1) AU2001278797A1 (de)
DE (1) DE60140218D1 (de)
ES (1) ES2333774T3 (de)
WO (1) WO2002014525A2 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1395669T3 (da) * 2001-01-26 2009-11-16 Selexis Sa Matriks bindingsregioner og fremgangsmåder til anvendelse af disse
EP1506286B1 (de) * 2002-05-24 2014-03-19 Merck Sharp & Dohme Corp. Neutralisierung eines menschlichen anti-igfr-antikörpers
US6933136B2 (en) 2002-09-20 2005-08-23 Novo Nordisk A/S Method for making recombinant proteins
WO2004027072A2 (en) * 2002-09-20 2004-04-01 Novo Nordisk A/S Method for making recombinant proteins
US7135338B2 (en) * 2003-06-11 2006-11-14 Dobeel Corporation Methods for overexpression of high molecular weight form of mannose binding lectin (MBL) and a specific formulation for active treatment for systemic infection with microorganism
KR100755931B1 (ko) * 2003-06-11 2007-09-06 (주)두비엘 고분자형 만노스 결합형 렉틴의 대량 생산방법 및 상기방법으로 제조된 만노스 결합형 렉틴 재조합 단백질의제제화
KR101269656B1 (ko) 2003-10-24 2013-05-30 셀렉시스 에스. 에이. Ｍａｒ 서열의 복합 트랜스펙션 방법에 의한 포유동물 세포에서의 고효율 유전자 전달 및 발현
US7326567B2 (en) 2003-11-12 2008-02-05 Schering Corporation Plasmid system for multigene expression
TW200526684A (en) 2003-11-21 2005-08-16 Schering Corp Anti-IGFR1 antibody therapeutic combinations
BRPI0419151A (pt) * 2004-10-28 2007-12-11 Dobeel Co Ltd método para a produção em massa de lectina ligante de manose multimérica
ATE471381T1 (de) 2005-03-04 2010-07-15 Celltrion Inc Expressionsvektor für tierische zelle mit wenigstens einer kopie von mar-dna-sequenzen am 3'-ende des transkriptionsterminationsbereichs eines gens sowie verfahren zur expression eines fremdgens unter verwendung des vektors
KR100779761B1 (ko) * 2005-10-28 2007-11-30 대한민국 인슐린 억제 및 사람 ｉｄｅ 유전자로 형질전환된 동물 및그 제조방법
KR100836745B1 (ko) * 2007-01-31 2008-06-10 (주)두비엘 Ｈｂｖ 백신 및 그의 제조 방법
EP2164971B1 (de) 2007-06-15 2015-12-09 Mogam Biotechnology Research Institute Verfahren zur herstellung von aktivem rekombinantem blutgerinnungsfaktor ix
CN101348786B (zh) * 2007-07-20 2011-05-11 谭孟群 一种人β珠蛋白基因及其重组腺相关病毒载体
EP2304027A1 (de) * 2008-06-10 2011-04-06 ISIS Innovation Limited Proteinexpression
KR101054362B1 (ko) 2008-07-03 2011-08-05 재단법인 목암생명공학연구소 재조합 단백질의 푸코스 함량을 감소시키는 방법
US8137933B2 (en) 2008-11-12 2012-03-20 Schering Corporation Mammalian expression vector pUHAB
EP2412810B1 (de) * 2009-03-27 2015-07-08 Hiroshima University Verfahren zur amplifikation und hochgradigen expression eines zielgens in säugerzellen und kit zur durchführung dieses verfahrens
CN102575264A (zh) * 2009-09-18 2012-07-11 瑟莱克斯公司 增加的转基因表达和加工的产品和方法
US20130034875A1 (en) * 2009-10-01 2013-02-07 Toto Ltd. Dna construct, and process for production of recombinant cho cell using same
EP2484761A4 (de) * 2009-10-01 2013-11-27 Toto Ltd Dna-konstrukt und verfahren zur herstellung rekombinanter cho-zellen damit
KR101607734B1 (ko) 2010-10-08 2016-03-30 카딜라 핼쓰캐어 리미티드 재조합 단백질의 높은 레벨의 발현을 위한 발현 벡터
US9062326B2 (en) 2011-03-30 2015-06-23 Pangen Biotech Inc. Expression vector for animal cells
US10175183B2 (en) 2011-03-31 2019-01-08 Kunimine Industries Co., Ltd. Agent for searching for protein crystallization conditions and method of searching for protein crystallization conditions
KR101420274B1 (ko) * 2011-06-13 2014-07-21 주식회사 종근당 Ｃｓｐ－ｂ ５＇ｓａｒ 인자를 포함하는 동물세포 발현 벡터 및 이를 이용한 재조합 단백질의 제조방법
MX353958B (es) 2011-09-22 2018-02-07 Amgen Inc Proteinas de union al antigeno cd27l.
SG10201900915WA (en) * 2011-12-22 2019-03-28 Hoffmann La Roche Expression vector element combinations, novel production cell generation methods and their use for the recombinant production of polypeptides
ES2791758T3 (es) 2011-12-22 2020-11-05 Hoffmann La Roche Organización de vectores de expresión, procedimientos de generación de células de producción novedosos y su uso para la producción recombinante de polipéptidos
AR091069A1 (es) 2012-05-18 2014-12-30 Amgen Inc Proteinas de union a antigeno dirigidas contra el receptor st2
UY35148A (es) 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
US9580486B2 (en) 2013-03-14 2017-02-28 Amgen Inc. Interleukin-2 muteins for the expansion of T-regulatory cells
US9708375B2 (en) 2013-03-15 2017-07-18 Amgen Inc. Inhibitory polypeptides specific to WNT inhibitors
CN103194455B (zh) * 2013-04-08 2014-10-15 山东省农业科学院畜牧兽医研究所 高效表达的猪粒细胞巨噬细胞集落刺激因子基因及其表达蛋白的用途
HUE056580T2 (hu) 2013-05-30 2022-02-28 Kiniksa Pharmaceuticals Ltd Onkosztatin-M-receptor antigénjét kötõ fehérjék
US11236338B2 (en) * 2013-09-05 2022-02-01 Sarepta Therapeutics, Inc. Antisense-induced exon2 inclusion in acid alpha-glucosidase
EP3041863A4 (de) 2013-09-05 2017-08-16 Amgen Inc. Fc-haltige moleküle mit vorhersagbaren, konsistenten und reproduzierbaren glycoformprofilen
KR101591823B1 (ko) 2013-12-27 2016-02-04 재단법인 목암생명공학연구소 증가된 유전자 발현능을 갖는 발현벡터
CR20170510A (es) 2015-04-10 2018-02-26 Amgen Inc Muteínas de interuquina 2 para la expansión de células t regulatorias
WO2016172485A2 (en) 2015-04-24 2016-10-27 Genentech, Inc. Multispecific antigen-binding proteins
EP3699269A1 (de) 2015-09-22 2020-08-26 F. Hoffmann-La Roche AG Expression von fc-haltigen proteinen
EP3359576B1 (de) 2015-10-08 2024-12-25 Zymeworks BC Inc. Antigenbindende polypeptidkonstrukte mit kappa- und lambda-leichtketten und verwendungen davon
ES2875274T3 (es) 2015-11-02 2021-11-10 Hoffmann La Roche Procedimientos de preparación de formas fucosiladas y afucosiladas de una proteína
WO2017184529A1 (en) 2016-04-18 2017-10-26 Sarepta Therapeutics, Inc. Antisense oligomers and methods of using the same for treating diseases associated with the acid alpha-glucosidase gene
JP7422480B2 (ja) 2016-05-04 2024-01-26 アムジエン・インコーポレーテツド 制御性ｔ細胞の増殖のためのインターロイキン－２変異タンパク質
WO2018150345A1 (en) * 2017-02-16 2018-08-23 De Vita Bio Life Sciences An expression vector
KR102611853B1 (ko) 2017-06-30 2023-12-08 자임워크스 비씨 인코포레이티드 안정화된 키메라 fabs
CN110343718A (zh) * 2018-04-03 2019-10-18 新乡医学院 一种高效稳定的细胞表达载体、表达系统及其制备方法、应用
PH12022550326A1 (en) 2019-08-13 2023-03-13 Amgen Inc Interleukin-2 muteins for the expansion of t-regulatory cells
IL293471A (en) 2019-12-17 2022-08-01 Amgen Inc Dual interleukin-2 / tnf receptor agonist for use in medicine
EP4735476A1 (de) 2023-06-27 2026-05-06 Amgen Inc. Ladungspaarmutationen zur ermöglichung der korrekten schwerleichtkettenpaarung
WO2025265034A1 (en) * 2024-06-20 2025-12-26 The Trustees Of The University Of Pennsylvania Transitory modulation of gene transcription through targeted mrna-lnp delivery of modified transcription activator-like effectors (tale)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956288A (en) * 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
US5108901A (en) * 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
AU673859B2 (en) 1992-10-05 1996-11-28 North Carolina State University Method for increasing expression and reducing expression variability of foreign genes in plant cells
DE69434931T2 (de) * 1993-04-02 2007-11-22 Rigel Pharmaceuticals, Inc., South San Francisco Methode zur selektiven inaktivierung der viralen replication
US5773695A (en) 1996-01-26 1998-06-30 North Carolina State University Plant nuclear scaffold attachment region and method for increasing gene expression in transgenic cells
IL127215A0 (en) 1996-06-06 1999-09-22 Novartis Ag Vectors comprising sar elements
CA2257719C (en) 1996-06-11 2005-05-31 Wesley B. Bruce A synthetic plant core promoter and upstream regulatory element
US6245974B1 (en) 1997-08-06 2001-06-12 North Carolina State University Matrix attachment regions
KR100313559B1 (ko) * 1998-07-22 2002-03-08 허영섭 수용성 TGFβ 수용체를 발현하는 재조합 세포주 및 전기세포주를 이용한 암치료 방법
WO2000018938A1 (en) * 1998-09-29 2000-04-06 Pioneer Hi-Bred International, Inc. Mar/sar elements flanking rsyn7-driven construct
DK1395669T3 (da) * 2001-01-26 2009-11-16 Selexis Sa Matriks bindingsregioner og fremgangsmåder til anvendelse af disse

Also Published As

Publication number Publication date
AU2001278797A1 (en) 2002-02-25
WO2002014525A3 (en) 2003-11-20
ES2333774T3 (es) 2010-03-01
WO2002014525A2 (en) 2002-02-21
KR100408844B1 (ko) 2003-12-06
EP1392835A2 (de) 2004-03-03
US7422874B2 (en) 2008-09-09
JP2004506428A (ja) 2004-03-04
KR20020010327A (ko) 2002-02-04
DE60140218D1 (de) 2009-11-26
EP1392835A4 (de) 2006-04-19
EP1392835B1 (de) 2009-10-14
US20040038394A1 (en) 2004-02-26
CN1444657A (zh) 2003-09-24
JP4138479B2 (ja) 2008-08-27
CN1262663C (zh) 2006-07-05

Similar Documents

Publication Publication Date Title
DE60140218D1 (de) Expressionsvektor für tierische zellen
WO1999040197A3 (en) Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
EA200600525A1 (ru) Еро-имитирующие миметичекие антитела человека с центральной шарнирной областью, композиции, способы и применения
ATE440951T1 (de) Verlängerte cdns, die für sekretierte proteine kodieren
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
ATE412765T1 (de) Expressionssystem für faktor viii
ATE474926T1 (de) Verwendung von clya hemolysin fur ausscheidung von fusionprotein
DE60041243D1 (de) Gebrauchsverfaheren eines neuen lysyloxidase-verwandten proteins
DE50009838D1 (de) Humanes antibiotisches protein
ATE309270T1 (de) ßSMOOTHENEDß PROTEINE AUS WIRBELTIEREN
EA200000270A1 (ru) КОМПОЗИЦИИ ДЛЯ ГЕНОТЕРАПИИ С ИСПОЛЬЗОВАНИЕМ ГЕНОВ, КОДИРУЮЩИХ СЕКРЕТИРУЕМЫЕ БЕЛКИ, ТАКИЕ КАК β-ИНТЕРФЕРОН, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
DK1283214T3 (da) Hidtil ukendte kollektiner
DK1287134T3 (da) Den humane spændings-gatede natriumkanal 1A-subunit og fremgangsmåder til anvendelse deraf
MY143222A (en) Expression vector for animal cell
NO20023015D0 (no) Humant heparanasebeslektet polypeptid og nukleinsyre
SE9800504D0 (sv) Novel peptide/protein, diagnostic reagent and kit for detection of rickettsiosis
WO2003082206A3 (en) Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses
DK0811068T3 (da) Humane DNase I varianter
DE50015355D1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz
NO991227L (no) PTX-sensitive G-proteiner, deres fremstilling og bruk
DE60137222D1 (de) Humanes trp-ähnliches kalziumkanalprotein-2 tlcc-2
DE60124910D1 (de) Menschliche twik-8 moleküle und ihre verwendung
FR2862660B1 (fr) Systeme d'expression inductible de proteines recombinantes chez les cyanobacteries.
ATE282704T1 (de) Isolierte und gereinigte humane lösliche guanylylcyclase alpha1/beta1 (hsgc alpha1/beta1)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties